Cargando…
Sporadic Metastatic Malignant Peripheral Nerve Sheath Tumour with an NF1 Mutation Responding to Trametinib: A Case Report
Sporadically occurring malignant peripheral nerve sheath tumours (MPNSTs) can have a variety of genomic alterations including altered NF1, leading to activation of the RAS-RAF-MEK-ERK signalling pathway. Trametinib is an inhibitor of MEK1 and MEK2. Here we present a case of a patient diagnosed with...
Autores principales: | Hitchen, Nadia, Cross, Matthew, Laking, George, Connor, Joanna, Korenbaum, Clement |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893996/ https://www.ncbi.nlm.nih.gov/pubmed/36743881 http://dx.doi.org/10.1159/000528743 |
Ejemplares similares
-
Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours
por: Porter, D. E., et al.
Publicado: (2009) -
Malignant Peripheral Nerve Sheath Tumour of the Maxilla
por: Sahai, Puja, et al.
Publicado: (2014) -
Immunohistochemical analysis of insulin-like growth factor 1 and its receptor in sporadic schwannoma/peripheral nerve sheath tumour
por: Matsubara, Fumiaki, et al.
Publicado: (2016) -
Malignant peripheral nerve sheath tumours in inherited disease
por: Evans, D Gareth R, et al.
Publicado: (2012) -
Malignant peripheral nerve sheath tumour in a sow
por: Resende, Talita P., et al.
Publicado: (2015)